Control of Ventilation

Published on 12/06/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 4 (3 votes)

This article have been viewed 18851 times

Control of Ventilation

Similar to the heartbeat, breathing is an automatic activity requiring no conscious awareness. Different from the heartbeat, breathing patterns can be consciously changed, although voluntary control is limited. Powerful neural control mechanisms overwhelm conscious control soon after one willfully stops breathing. The normal unconscious cycle of breathing is regulated by complex mechanisms that continue to elude complete understanding. The rhythmic cycle of breathing originates in the brainstem, mainly from neurons located in the medulla. Higher brain centers and many systemic receptors and reflexes modify the medulla’s output. These different structures function in an integrated manner, precisely controlling ventilatory rate and depth to accommodate the body’s gas exchange needs, whether at rest, during exercise, or in disease.

Medullary Respiratory Center

Rhythmic neural impulses responsible for ventilation originate in the medulla oblongata of the brainstem (Figure 11-1). Animal experiments show that transection of the brainstem just below the medulla (see level IV, Figure 11-1) stops all ventilatory activity. However, rhythmic breathing continues after the brainstem is transected just above the pons (see level I, Figure 11-1).

Physiologists previously thought that separate inspiratory and expiratory neuron “centers” in the medulla were responsible for the cyclical pattern of breathing. It was believed that inspiratory and expiratory neurons fired by self-excitation and that they mutually inhibited one another. It is now known that inspiratory and expiratory neurons are anatomically intermingled and do not necessarily inhibit one another.1 These neurons are widely dispersed in the medulla; the dorsal respiratory groups (DRG) contain mainly inspiratory neurons, whereas the ventral respiratory groups (VRG) contain intermingled inspiratory and expiratory neurons.

Dorsal Respiratory Groups

As shown in Figure 11-1, the DRG consist of mainly inspiratory neurons located bilaterally in an area called the nucleus of the tractus solitarius. These neurons send impulses to the phrenic and external intercostal motor nerves in the spinal cord, providing the main stimulus for inspiration.1 Many DRG nerves extend into the VRG, but few VRG fibers extend into the DRG. Thus, reciprocal inhibition is an unlikely explanation for rhythmic, spontaneous breathing.1 The DRG consists of two neuron populations, one of which is inhibited by deep lung inflation (causing cessation of inspiratory effort), whereas the other is excited by lung inflation (causing continued inspiratory effort).1 These neurons are involved in the Hering-Breuer and Head’s reflexes described later in this chapter.

The vagus and glossopharyngeal nerves transmit many sensory impulses to the DRG from the lungs, airways, peripheral chemoreceptors, and joint proprioceptors. These impulses modify the basic breathing pattern generated in the medulla.

Ventral Respiratory Groups

VRG neurons are located bilaterally in the medulla in two separate nuclei that contain both inspiratory and expiratory neurons (see Figure 11-1). Some inspiratory VRG neurons send motor impulses through the vagus nerve to the laryngeal and pharyngeal muscles, abducting the vocal cords and increasing the diameter of the glottis. Other VRG inspiratory neurons transmit impulses to the diaphragm and external intercostal muscles. Still other VRG neurons have mostly expiratory discharge patterns and send impulses to the internal intercostal and abdominal expiratory muscles. The most rostral (toward the head) part of the VRG, Bötzinger’s complex (see Figure 11-1), contains the only expiratory neurons known to inhibit the inspiratory VRG and DRG impulses.2

CLINICAL FOCUS 11-1   Use of Dorsal Respiratory Group Neural Impulses to Trigger Mechanical Ventilation: Neurally Adjusted Ventilatory Assist

Critically ill patients in hospital intensive care units often cannot breathe adequately on their own and require mechanical ventilation. The electrical impulses of the DRG neurons can be used to adjust the mechanical ventilator’s inspiratory gas flow to meet the patient’s inspiratory demands precisely. One challenge of mechanical ventilation is to ensure that the patient and the ventilator are in synchrony, such that the ventilator senses the patient’s slightest inspiratory effort and immediately provides gas flow to the patient in an amount proportional to the inspiratory effort.

Neurally adjusted ventilatory assist (NAVA) is a mode that accomplishes this task by measuring the diaphragm’s electrical activity in response to phrenic nerve impulses; this kind of measurement is called electromyography (EMG). A specially designed thin tube (nasogastric tube) with a series of EMG electrodes at one end is inserted into the patient’s esophagus by way of the nasal cavity and advanced until the electrodes are adjacent to the diaphragm. When the patient wants to take a breath, electrical impulses from the medulla’s DRG neurons travel down the phrenic nerves to the diaphragm causing it to contract, which produces an electrical current proportional to the level of muscle activity. The nasogastric tube’s EMG electrodes sense the electrical current and transmit this information to the ventilator’s microprocessor, which instructs the ventilator to generate an inspiratory gas flow rate that is proportional to the signal strength. Through the ventilator’s control panel, the clinician can set how much pressure the ventilator applies to the patient’s airway for each millivolt of EMG activity. The ventilator assists the patient’s inspiratory efforts in a way that is precisely matched to the EMG signal strength—that is, proportional to the patient’s inspiratory effort. The greater the inspiratory effort, the more pressure the ventilator applies; with less effort, the less pressure is applied. In theory, NAVA should provide the patient with a more natural and comfortable mode of mechanical ventilation because it recognizes the inspiratory signal high up in the neural pathway that controls breathing.14

Respiratory Rhythm Generation

The exact origin of the basic rhythmic pattern of breathing is unknown; no single group of pacemaker cells have been identified. The Bötzinger complex and a structure located between it and the VRG, the pre-Bötzinger complex, are thought to be responsible for rhythmic breathing.2 Two predominant theories of rhythm generation are the pacemaker hypothesis and the network hypothesis. The pacemaker hypothesis holds that certain medullary cells have intrinsic pacemaker properties—that is, rhythmic self-exciting characteristics—and that these cells drive other medullary neurons. The network hypothesis suggests that rhythmic breathing is the result of a particular pattern of interconnections between neurons dispersed throughout the rostral VRG, the pre-Bötzinger complex, and the Bötzinger complex. This hypothesis assumes that certain populations of inspiratory and expiratory neurons inhibit one another and that one of the neuron types fires in a self-limiting way, such that it becomes less responsive the longer it fires. There is no definitive proof of either hypothesis; the precise origin of respiratory rhythm generation remains elusive.

Inspiratory Ramp Signal

The dorsal and ventral inspiratory neurons do not send an abrupt burst of impulses to the inspiratory muscles; instead, their firing rate increases gradually after expiration ceases, creating a smoothly increasing ramp signal (Figure 11-2). This ramp signal leads to a progressively stronger contraction of inspiratory muscles, smoothly and gradually inflating the lungs instead of filling them in an abrupt inspiratory gasp. During exercise, various peripheral reflexes and receptors influence the medullary neurons, steepening the inspiratory ramp signal and filling the lungs more rapidly.

As the inspiratory ramp signal strengthens, inhibitory neurons begin to fire with increasing frequency.2 After approximately 2 seconds, these restraining impulses become strong enough to switch off the inspiratory signal abruptly. Expiration proceeds for about 3 seconds.3 As expiration begins, inspiratory neurons fire briefly, “braking” the early phase of expiration by maintaining some inspiratory muscle tone (see Figure 11-2). Inspiratory neuronal activity completely stops in the last phase of expiration. The inhibitory neurons that switch off the inspiratory ramp arise from the pneumotaxic center and pulmonary stretch receptors, which are discussed in the next section.

Pontine Centers

If the brainstem is transected above the medulla (see Figure 11-1, level III), spontaneous respiration continues, although in a more irregular pattern; thus, the pons promotes rhythmic breathing by modifying the output of the medullary centers. Figure 11-1 shows two groups of neurons in the pons: (1) the apneustic center and (2) the pneumotaxic center.

Apneustic and Pneumotaxic Centers

The two respiratory centers in the pons (apneustic and pneumotaxic) have been identified through animal brain transection experiments. If the brainstem is severed at the midpons level (see Figure 11-1, level II), and the vagus nerves connecting this area with the lower parts of the brain and spinal cord are also cut, a breathing pattern called apneusis results (Figure 11-3). Apneusis consists of prolonged inspiratory gasps interrupted by occasional expirations. The apneustic center is thought to be in a region in the lower pons, but it has never been anatomically identified with certainty.2 Its existence and function can be demonstrated only if its connections to the higher pneumotaxic center are severed and the vagus nerves are cut. Under these circumstances, the area in the lower pons (i.e., the apneustic center) sends signals to the DRG neurons, preventing the inspiratory ramp signal from being switched off.3 Apparently, vagal and pneumotaxic center impulses hold the apneustic center’s stimulatory effect on DRG neurons in check because apneusis does not occur if the vagus is left intact (see Figure 11-3).

The pneumotaxic centers are bilateral groups of neurons in the upper pons (see Figure 11-1). These centers control the off-switch point of the DRG’s inspiratory ramp signal, sending inhibitory impulses to medullary inspiratory neurons; thus, pneumotaxic signals control the length of inspiration. Strong pneumotaxic signals shorten the inspiratory time and increase the respiratory rate. Weak signals produce prolonged inspiration and large tidal volumes. The primary function of the pneumotaxic center is to limit inspiration and hold apneustic center impulses in check. The exact nature of the interaction between the apneustic and pneumotaxic centers remains poorly understood; they apparently work together to control the depth of inspiration.3 The effect of the pontine centers on the lower medullary centers seems to be fine-tuning the respiratory pattern because the transection of the brainstem between the pons and medulla (see Figures 11-1, level III, and 11-3) results in an irregular breathing pattern.1

Reflex Control of Breathing

The central ventilatory drive arising from the medulla is modified by various inputs from peripheral sensors. These sensors are located in the lungs, muscles, and joints.

Hering-Breuer Inflation Reflex

The Hering-Breuer inflation reflex, described by Hering and Breuer in 1868, is generated by stretch receptors located in smooth muscle of large and small airways. These receptors are called slowly adapting receptors because their activity continues as long as the stimulus persists (see Chapter 2). When stretched, these receptors send inhibitory impulses through the vagus nerve to the DRG neurons, stopping further inspiration. Thus, the Hering-Breuer reflex has an effect similar to that of the pneumotaxic center.3 The Hering-Breuer reflex in adults is activated only at large tidal volumes (≥800 to 1000 mL) and is apparently not an important control mechanism in quiet breathing. However, this reflex is important in regulating the respiratory rate and depth during moderate to strenuous exercise.2

Diseases associated with low lung compliance (i.e., strong elastic retractive forces) may stimulate the inflation stretch receptors by increasing the mechanical stress acting on the airways during inspiratory efforts.2 This stimulation tends to increase the respiratory rate because it sends an early inhibitory signal, shortening the inspiratory phase.

Various combinations of respiratory rate and tidal volume can produce the level of ventilation needed to meet metabolic gas exchange demands, but there is always a specific combination that results in the least work. The information stretch receptors send to the medullary centers, which can be consciously sensed, probably helps to establish this optimal combination. The sensation of dyspnea is thought to be produced when the medullary centers demand a level of ventilation greater than the actual ventilation achieved.2

J-Receptors

C-fibers in the lung parenchyma near pulmonary capillaries are called juxtacapillary receptors, or J-receptors (see Chapter 1). They are stimulated by alveolar inflammatory processes (pneumonia), pulmonary vascular congestion (congestive heart failure), and edema. J-receptor stimulation causes rapid, shallow breathing; a sensation of dyspnea; and expiratory narrowing of the glottis. Expiratory narrowing of the glottis causes grunting on expiration, especially in infants.

Muscle Spindles

Muscle spindles in the diaphragm and intercostal muscles are part of a reflex arc that helps the muscles adjust to an increased load. Muscle spindles are stretch-sensing elements located on intrafusal muscle fibers, which are arranged in parallel with the main extrafusal muscle fibers (Figure 11-4). The extrafusal skeletal muscle fibers that elevate the ribs (see Figure 11-4) are innervated by different motor fibers (alpha motor fibers) than the intrafusal spindle fibers (gamma motor fibers). As the main extrafusal muscle fiber and the intrafusal fibers contract together in parallel, the spindle-sensing element stretches and sends impulses over spindle afferent nerves directly to the spinal cord (see Figure 11-4). The number of impulses sent is proportional to the spindle’s stretch. The spindle’s afferent (sensory) nerve synapses directly with the same alpha motor neuron in the spinal cord that sends motor impulses back to the main extrafusal muscle fiber; this creates a single synapse reflex arc. When stimulated by the spindle’s afferent nerve signal, the alpha motor neuron sends signals to only the main extrafusal muscle fibers, causing them to contract with greater force, which unloads and shortens the adjacent intrafusal muscle fibers. As a result, the stretch-sensitive spindle is unloaded, and its impulses cease. In this way, inspiratory muscle force automatically adjusts to the load imposed by decreased lung compliance or increased airway resistance.

Chemical Control of Ventilation

The body maintains the proper amounts of oxygen, carbon dioxide, and hydrogen ions in the blood, mainly by regulating ventilation. Physiological mechanisms that monitor these substances in the blood allow ventilation to respond appropriately to maintain homeostasis. An increase in blood H+ concentration stimulates specialized nerve structures called chemoreceptors. Consequently, the chemoreceptors transmit impulses to the medulla, increasing ventilation. Centrally located chemoreceptors in

CLINICAL FOCUS 11-2   Vagovagal Reflex Stimulation during Endotracheal Suctioning

Patients who have endotracheal tubes in place have impaired cough effectiveness because they cannot close the glottis to generate the necessary high intrapulmonary pressure. A suction catheter is frequently inserted into the endotracheal tube and trachea to remove excess secretions. The tip of the catheter often enters the mainstem bronchi during suctioning.

Consider a situation in which you are suctioning the airway of a patient whose lungs are being mechanically ventilated; the cardiac monitoring screen at the patient’s bedside shows a sudden decrease in heart rate and blood pressure. On withdrawing the catheter and manually ventilating the patient’s lungs with 100% oxygen, you note that the heart rate and blood pressure return to their previous levels. What is the explanation for your patient’s response?

Discussion

The suction catheter mechanically stimulated tracheal and bronchial irritant receptors, eliciting a vagovagal reflex. The heart responds to vagal (parasympathetic) stimulation by slowing its rate (bradycardia). Severe bradycardia decreases the cardiac output. Consequently, blood pressure decreases. Irritation from the suction catheter also stimulates cough receptors in the trachea and carina, eliciting vigorous cough efforts. Such coughing may increase intrathoracic pressure enough to reduce momentarily the venous blood return to the heart, reducing the blood pressure momentarily. These complications of endotracheal suctioning are best avoided by using the following technique:

The vagovagal reflex is also often elicited during endotracheal intubation. A local anesthetic sprayed into the pharynx and applied to the endotracheal tube helps blunt this reflex.

the medulla respond to H+, which normally arises from the reaction between dissolved CO2 and H2O in the cerebrospinal fluid (CSF). Peripherally located chemoreceptors in the fork of the common carotid arteries and the aortic arch are also sensitive to H+ and thus are indirectly sensitive to CO2. In addition, peripheral chemoreceptors are indirectly sensitive to hypoxemia because hypoxemia increases their sensitivity to hydrogen ions.2

Central (Medullary) Chemoreceptors

Hydrogen ions, not CO2 molecules, stimulate highly responsive chemosensitive nerve cells, located bilaterally in the medulla. Nevertheless, these central chemoreceptors are extremely responsive to CO2 because the [H+] surrounding them is dependent on the reaction between CO2 and H2O in their local environment. The chemoreceptors are not in direct contact with arterial blood. Instead, they are bathed in the cerebral spinal fluid, separated from the blood by a semipermeable membrane called the blood-brain barrier. This membrane is almost impermeable to H+ and HCO3, but it is freely permeable to CO2. When the PaCO2 rises, CO2 diffuses rapidly through the blood-brain barrier into the CSF. In the CSF, CO2 reacts with H2O to form hydrogen ions (Figure 11-5); this stimulates the central chemoreceptors, which in turn stimulate the medullary inspiratory neurons. Because CSF contains no protein buffers, CO2 diffusion from the blood into the CSF increases [H+] almost instantly, exciting the central chemoreceptors within seconds. Through this mechanism, alveolar ventilation increases by approximately 2 to 3 L/min for each millimeter of mercury increase in PaCO2.4 In this indirect fashion, PaCO2 is the principal minute-to-minute stimulus for ventilation mediated through the central chemoreceptors.

Figure 11-6 compares the ventilatory response to increased PaCO2 with the ventilatory response to increased arterial [H+] arising from fixed acid accumulation (i.e., acidemia from a nonrespiratory cause). A great change in ventilation occurs between PaCO2 values of 40 mm Hg and 80 mm Hg compared with a relatively small change in ventilation caused by a fixed acid–induced fall in arterial pH from 7.40 to 7.00 (see Figure 11-6).

Hydrogen ions in the arterial blood do not readily diffuse across the blood-brain barrier and thus cannot stimulate the medullary chemoreceptors to any great extent; the effect of hydrogen ions is mediated mainly through the less responsive peripheral chemoreceptors, which are discussed in the next section.

The stimulatory effect of CO2 on the central chemoreceptors gradually declines over 1 to 2 days because of renal compensatory responses. The kidneys increase blood bicarbonate ion [HCO3] concentration in response to respiratory acidosis (see Chapter 10), which returns blood pH to the normal range. The increased number of bicarbonate ions in the blood eventually diffuses across the blood-brain barrier into the CSF where they buffer H+ and bring the CSF pH back to normal; this removes the stimulus to the chemoreceptors, and ventilation decreases. Although an increase in PaCO2 has an extremely powerful effect on ventilation, its effect is greatly weakened after 1 or 2 days of adaptation.

Unimportance of Oxygen as a Primary Controller of Ventilation

Although it would seem that oxygen should play an important role in controlling ventilation, oxygen molecules have no effect on the medullary chemoreceptors. Ventilation does not control arterial PO2 or hemoglobin oxygen saturation with any degree of precision. If an individual’s normal resting ventilation is cut in half, PaO2 decreases from 100 mm Hg to about 60 mm Hg, which still produces an oxygen hemoglobin saturation of about 90% (see Chapter 8). If ventilation then increases, and a normal PaO2 of 100 mm Hg is restored, oxyhemoglobin saturation increases to about 98%; in other words, an increase in ventilation that raises the PaO2 from 60 mm Hg to 100 mm Hg adds only marginally more oxygen to the blood. Even maximal hyperventilation cannot raise the PaO2 higher than 125 to 130 mm Hg (refer to the alveolar air equation in Chapter 7). This degree of hyperventilation (which increases the PaO2 from 100 mm Hg to 130 mm Hg) increases the hemoglobin saturation by only 1.5%. Thus, in healthy individuals under normal conditions, ventilation ranging from about half normal to many times normal produces very little change in arterial oxygen content; this is explained by the fact that the oxyhemoglobin equilibrium curve is nearly flat from 60 to 125 mm Hg. In contrast, the CO2 equilibrium curve is practically linear in the physiological range, which means that doubling the alveolar ventilation decreases the PaCO2 to half of normal, whereas cutting alveolar ventilation to half normal doubles the PaCO2. Such changes in PaCO2 drastically affect the blood pH. Thus, it makes sense that carbon dioxide (not oxygen) is the main controller of ventilation.

Peripheral Chemoreceptors

The peripheral chemoreceptors are small, highly vascular tissues known as the carotid and aortic bodies. The carotid bodies are small organs located bilaterally in bifurcations of the common carotid arteries (Figure 11-7). The aortic bodies are found in the arch of the aorta. These neural structures increase their firing rates in response to increased arterial [H+] regardless of its origin—that is, whether from fixed acid accumulation or increased CO2. The carotid bodies contain far more chemoreceptors than the aortic bodies; they send their impulses over the glossopharyngeal nerve to medullary DRG and VRG, whereas the aortic bodies send their impulses over the vagus nerve (see Figure 11-7). The carotid bodies exert much more influence over the respiratory centers than do the aortic bodies, especially with respect to arterial hypoxemia and acidemia.1

The carotid bodies receive an extremely high blood flow, about 20 times their weight each minute.3 This extremely high flow rate means the carotid bodies have little time to remove oxygen from the blood, so the venous blood leaving the carotid bodies has almost the same oxygen content as the arterial blood entering them. The carotid bodies are exposed at all times to arterial (not venous) blood, and they sense arterial (not venous) [H+].

Response to Decreased Arterial Oxygen

Traditionally, it was believed that the carotid bodies directly sensed decreased PaO2 levels, implying that arterial hypoxemia represents an independent drive to breathe—the so-called hypoxic drive. Although peripheral chemoreceptors fire more frequently in the presence of arterial hypoxemia, they do so only because hypoxemia makes them more sensitive to hydrogen ions.2 That is, in the presence of hypoxemia, carotid body sensitivity to a given [H+] increases; in this way, hypoxia increases ventilation for any given pH. Conversely, a very high PO2 (hyperoxia) decreases carotid body sensitivity to [H+]. Thus, the carotid bodies respond to arterial hypoxemia but only because hypoxia makes them more sensitive to [H+]; this implies that if the arterial [H+] is extremely low, as in severe alkalemia, hypoxemia has little effect on the carotid bodies.2 Simply stated, the ultimate effect of hypoxemia is to increase the neural firing rate of the peripheral chemoreceptors, which increases minute ventilation.

Because carotid body tissues have extremely high blood flow rates, they respond to decreased PaO2 (in the indirect way just described) rather than to an actual decrease in arterial oxygen content. That is, the carotid bodies’ extraction of oxygen from each unit of rapidly flowing blood is so small that their oxygen needs are met entirely by dissolved oxygen in the plasma. This is why conditions associated with low arterial oxygen content but normal PaO2 (e.g., anemia and carbon monoxide poisoning) do not stimulate ventilation.4

When pH and PaCO2 are normal (i.e., pH = 7.40 and PaCO2 = 40 mm Hg), the carotid bodies’ rate of nerve impulse transmission does not increase significantly until PaO2 decreases to about 60 mm Hg.4 As PaO2 decreases from 60 mm Hg to 30 mm Hg, the rate of impulse transmission increases sharply and linearly because hypoxemia makes the carotid bodies much more sensitive to a pH of 7.40 (Figure 11-8). A decrease in PaO2 from 60 mm Hg to 30 mm Hg corresponds to the sharpest decrease in oxygen content on the oxygen-hemoglobin equilibrium curve—that is, the steepest part of the curve. Arterial hypoxemia does not stimulate ventilation greatly until the PaO2 decreases to values less than 60 mm Hg; this is why ventilation increases as one ascends to high altitudes. Decreased barometric pressure at high altitudes decreases inspired and arterial PO2 values, which increases the sensitivity of peripheral chemoreceptors to hydrogen ions. However, the resulting increase in ventilation is less than expected because hyperventilation increases arterial pH by decreasing PaCO2 and subsequently, blood [H+]. The increase in arterial pH depresses the medullary respiratory center, counteracting the excitatory effect of decreased PaO2 on peripheral chemoreceptors. However, lung mechanics in certain conditions, such as advanced chronic obstructive pulmonary disease, are so deranged that the stimulatory effect of hypoxemia on ventilation fails to decrease PaCO2 regardless of the patient’s effort. In such instances, there is no alkalosis to counteract stimulatory effects of hypoxemia on ventilation.

Response to Increased Arterial Carbon Dioxide Pressure and Hydrogen Ions

Similar to the central chemoreceptors, the peripheral chemoreceptors are directly sensitive to hydrogen ions and indirectly sensitive to PCO2. That is, ventilation controls arterial [H+] by controlling PaCO2 (which generates H+ through the hydration reaction), and in this way, the peripheral chemoreceptors are sensitive to PaCO2. Increased PaCO2 increases blood [H+], directly exciting the carotid bodies and stimulating ventilation. However, this increase in ventilation is far less than the increase produced by the central chemoreceptors when they are stimulated by CO2-generated H+. The peripheral chemoreceptors account for only 20% to 30% of the ventilatory response to hypercapnia.4 However, the peripheral chemoreceptors respond to a fixed acid-induced rise in arterial [H+] about five times more quickly than the central chemoreceptors.3 In contrast to the central chemoreceptors, the carotid bodies are directly exposed to arterial blood. Thus, the initial ventilatory response to fixed acid accumulation is quick, offsetting the fact that hydrogen ions cross the blood-brain barrier with great difficulty.

As stated earlier, hypoxemia increases the sensitivity of the peripheral chemoreceptors to hydrogen ions and thus indirectly to PaCO2. Conversely, an excessively high PaO2 (hyperoxia) decreases the peripheral chemoreceptors’ PaCO2 sensitivity to almost zero.2 Thus, when PaO2 is increased, the ventilatory response to PaCO2 is mainly mediated by the central chemoreceptors, which are unaffected by hypoxemia.

The fact that the only effect of hypoxia on the peripheral chemoreceptors is to increase their sensitivity to arterial [H+] and subsequently to PaCO2 means that (1) high PO2 renders the peripheral chemoreceptors almost unresponsive to PCO2, and (2) decreased PaCO2 (low arterial [H+]) renders the peripheral chemoreceptors almost unresponsive to hypoxemia.2 Coexisting arterial hypoxemia, acidemia, and high PaCO2 (i.e., asphyxia) maximally stimulate the peripheral chemoreceptors (see Figure 11-8).

Control of Breathing during Chronic Hypercapnia

A sudden increase in PaCO2 causes an immediate increase in ventilation because CO2 rapidly diffuses from the blood into the CSF, increasing [H+] surrounding the central chemoreceptors. On the other hand, if PaCO2 increases gradually over many years, as might occur in the development of severe COPD and steadily worsening lung mechanics, the kidneys compensate by increasing the plasma bicarbonate concentration, keeping the arterial pH within normal limits (see Chapter 10). As plasma bicarbonate levels increase, these ions slowly diffuse across the blood-brain barrier, keeping CSF pH in its normal range. Because the central chemoreceptors respond to [H+], not the CO2 molecule, they sense a normal pH environment, even though the PaCO2 is abnormally high.

This adaptation explains why chronically elevated PaCO2 in patients with severe COPD does not overly stimulate ventilation. Instead, the hypoxemia that accompanies chronic hypercapnia becomes the minute-to-minute breathing stimulus in the roundabout way discussed previously: Hypoxemia increases the peripheral chemoreceptors’ sensitivity to [H+], increasing the nerve impulses they transmit to the medulla, stimulating ventilation. Patients with severe COPD are invariably hypoxemic when breathing room air because their lungs have severe mismatches in ventilation and blood flow. It stands to reason that breathing supplemental oxygen would increase the PaO2 and make the carotid bodies less sensitive to [H+], which would decrease ventilation further and thus increase PaCO2

Oxygen-Associated Hypercapnia

An acute increase in PaCO2 sometimes occurs after oxygen is given to patients with severe COPD who are chronically hypoxemic and hypercapnic; the reason for this phenomenon continues to be a subject of much debate and misunderstanding. The traditional explanation has been that oxygen breathing removes hypoxemia’s stimulatory effect on the peripheral chemoreceptors. As explained in the previous section, the ventilatory stimulus of the peripheral chemoreceptors increases significantly when the PaO2 decreases to less than 60 mm Hg; this is true in hypoxemic patients with or without a history of chronic hypercapnia. If breathing supplemental oxygen increases the PaO2 to levels greater than 60 mm Hg, it stands to reason that the stimulatory effect of the peripheral chemoreceptors on ventilation would diminish, which would decrease ventilation and increase PaCO2. This explanation for the increase in PaCO2 after oxygen administration is widely accepted in reference to hypoxemic patients without COPD—for example, a patient with pneumonia whose hypoxemia is corrected by O2 administration; it seems to be challenged only in reference to patients with COPD who are chronically hypercapnic. The major reason

CLINICAL FOCUS 11-3   Chronic Physiological Effect of Low Inspired Oxygen at High Altitude

You and some friends decide to vacation in the mountains of Colorado and climb a 14,000-foot peak (barometric pressure = 460 mm Hg). You are currently at sea level. You drive to your destination in 1 day, and the next morning you hike to the peak of the 14,000-foot mountain and set up camp for the night.

Questions and Discussion

< ?xml:namespace prefix = "mml" />PIO2=0.21(46047)=87mm Hg

image

PAO2=0.21(46047)(40×1.2)=39mm Hg

image

PaO2 would be a few millimeters of mercury lower than this because of a normal P(A-a)O2 difference (secondary to normal anatomical shunting). Actually, your ventilation does not remain the same; hypoxia makes your peripheral chemoreceptors more sensitive, which stimulates ventilation quite strongly at this PaO2.

PAO2=0.21(46047)(20×1.2)=63mm Hg

image

(Because of the normal P(A-a)O2, PaO2 would be in the upper 50s.)

A PaCO2 of 20 mm Hg immediately decreases CSF PCO2 to 20 mm Hg and creates an even greater CSF alkalosis than it creates in the blood because the blood-brain barrier is nearly impermeable to HCO3 ions. That is, as CO2 rapidly diffuses out of the CSF in response to the low PaCO2, HCO3 cannot follow. Your central chemoreceptors are exposed to an alkaline environment, which works to suppress their ventilatory stimulus, counteracting the peripheral chemoreceptor stimulus arising from hypoxia. These events limit the extent to which hypoxia increases your ventilation. However, as time progresses, HCO3 gradually diffuses out of the CSF across the blood-brain barrier and into the blood, which brings the CSF pH back toward normal. At the same time, your kidneys compensate for the hyperventilation-induced alkalemia by excreting HCO3 ions; over the next 24 hours, this brings your blood pH back toward normal—even though the PaCO2 is still low. With the inhibiting effects of an alkalotic CSF removed, the hypoxic stimulus gradually increases ventilation again. On arriving at the mountaintop, about 24 hours pass before your minute ventilation increases to its maximum level. This considerable increase in ventilation greatly improves your ability to tolerate the low PIO2.

why alternative explanations have been sought is that the reduction in minute ventilation after oxygen breathing in patients with advanced COPD is not always severe enough to account for the increased PaCO2.5,6

The question is not whether hypoxemia heightens peripheral chemoreceptor sensitivity to [H+] in hypercapnic patients with COPD (it does) but whether oxygen administration decreases this sensitivity sufficiently to account for the observed increase in PaCO2. An additional pertinent question is whether an acute increase in PaCO2 on top of already elevated PaCO2 stimulates the medullary chemoreceptors in these patients as it does in healthy patients.

Several investigators have suggested that oxygen breathing worsens the lungs’ ventilation-perfusion (V˙/Q˙image) relationships, creating more dead space.5,6 Other investigators suggested that oxygen-induced hypercapnia is caused by the combined effects of hypoxic stimulus removal and redistribution of V˙/Q˙image relationships in the lungs.79

V˙/Q˙image relationships may worsen in the lungs after oxygen administration because improved oxygenation abolishes hypoxic pulmonary vasoconstriction in poorly ventilated lung regions. The resulting reduction in vascular resistance shifts more blood flow to these underventilated areas, drawing blood flow away from well-ventilated regions (Figure 11-9). As poorly ventilated regions receive more blood flow, they become even less ventilated as oxygen-rich inspired gas washes out resident nitrogen gas, making alveoli more subject to absorption atelectasis; that is, oxygen may be absorbed by the pulmonary circulation more rapidly than the slowed ventilation can replenish it (notice the further decreased V˙image in Figure 11-9, B). As a result, inspired gas flows preferentially to the already well-ventilated alveoli (see Figure 11-9, B), increasing their V˙/Q˙image ratios. The increased V˙/Q˙image in these alveoli is further exaggerated because they lose some blood flow to the poorly ventilated regions, which now have lower vascular resistance owing to oxygen breathing. In the end, more blood flow is directed to poorly ventilated alveoli, which takes blood flow away from well-ventilated alveoli. The key point is that when already underventilated alveoli receive additional blood flow, arterial blood PCO2 increases further. These events occur without a decline in overall minute ventilation.

Although some investigators believe the mechanisms just described explain why oxygen administration induces hypercapnia in patients with COPD, other studies support an equally important role for oxygen suppression of the hypoxic ventilatory stimulus.79 These studies demonstrated that in exacerbated, chronically hypercapnic patients with COPD, oxygen administration significantly reduced their ventilation8,9 and elevated the PaCO2 level required to stimulate ventilation via the medullary chemoreceptors.7

The diagnosis of COPD on a patient’s medical record does not automatically mean the patient has a chronically increased PaCO2 or that hypercapnia will follow oxygen administration. These characteristics are present only in patients with severe end-stage disease, which includes only a small percentage of patients with the diagnosis of COPD; therefore, concern about oxygen-induced hypercapnia and acidemia is not warranted in most patients with a diagnosis of COPD. In any event, the fear of inducing hypoventilation and hypercapnia is never a justifiable rationale for withholding oxygen from acutely hypoxemic patients with COPD. Tissue oxygenation is an overriding priority; oxygen must never be withheld for any reason from hypoxemic COPD patients experiencing exacerbations of their disease. The clinician must be prepared to mechanically support the patient’s ventilation if severe hypoventilation occurs.

Medullary Response to Acute Carbon Dioxide Increase in Chronic Hypercapnia

As discussed earlier, the kidneys compensate for the acidic effects of chronic hypercapnia by raising the plasma bicarbonate level, keeping the medullary chemoreceptor pH environment in the normal range. However, the medullary chemoreceptors can still respond to further acute increases in PaCO2. A sudden rise in PaCO2 means more CO2 molecules immediately cross the blood-brain barrier into the CSF generating hydrogen ions that stimulate the medullary chemoreceptors.

The resulting ventilatory response is depressed for both chemical and mechanical reasons: (1) the blood’s increased buffering capacity (high HCO3 level) in chronic hypercapnia prevents arterial pH from decreasing as sharply as it would in normal conditions, and (2) abnormal breathing mechanics impair the lungs’ ability to increase ventilation appropriately. To illustrate the blood’s changed buffering capacity, compare a healthy person (pH = 7.40; PaCO2 = 40 mm Hg; HCO3 = 24 mEq/L) with a chronically hypercapnic patient (pH = 7.38; PaCO2 = 60 mm Hg; HCO3 = 34 mEq/L). If PaCO2 suddenly increases by 30 mm Hg in both individuals, the healthy person’s arterial pH decreases to 7.21, and the hypercapnic patient’s pH decreases to only 7.24. (These values are calculated using the Henderson-Hasselbalch equation, assuming a 1-mEq/L increase in plasma HCO3 concentration for each acute 10-mm Hg increase in PaCO2.) Thus, the chronically hypercapnic patient’s central chemoreceptors experience less stimulation than the central chemoreceptors of the healthy person for the same increase in PaCO2. Several investigators have confirmed the reduced ventilatory response to CO2 in patients with chronic hypercapnia.10,11

Ventilatory Response to Exercise

During strenuous exercise, CO2 production and oxygen consumption may increase 20-fold.3 These increases are extremely well matched by ventilation and cardiac output. Ventilation keeps pace with CO2 production, keeping PaCO2, PaO2, and arterial pH remarkably constant. What drives the greatly increased ventilation that accompanies exercise if arterial blood gases do not change?

The exact mechanisms responsible for increased ventilation during exercise are not well understood. Figure 11-10 illustrates the three stages of exercise: I, onset; II, period of adjustment; III, steady state. Especially mysterious is the abrupt increase in ventilation at the onset of exercise (stage I), long before any chemical or humoral changes can occur in the body. The two predominating theories are as follows: (1) when the cerebral motor cortex sends impulses to exercising muscles, it apparently sends collateral excitatory impulses to the medullary respiratory centers, and (2) exercising limbs moving around their joints stimulate proprioceptors, which transmit excitatory impulses to the medullary centers.3 Evidence also suggests that the sudden increase in ventilation at the onset of exercise is a learned response.3 In other words, with repeated experience, the brain learns to anticipate the proper amount of ventilation required to maintain normal blood gases during exercise.

Abnormal Breathing Patterns

Common abnormal breathing patterns include (1) Cheyne-Stokes breathing, (2) Biot’s breathing, (3) apneustic breathing, and (4) central reflex hypopnea and hyperpnea. In

CLINICAL FOCUS 11-4   Oxygen-Induced Hypoventilation in Chronic Hypercapnia

A patient with advanced COPD and chronic hypercapnia comes into the emergency department agitated, short of breath, and hypoxemic. His respiratory rate is 32 breaths per minute. Room air arterial blood gases are as follows:

Emergency department personnel immediately administer oxygen by using an air-entrainment mask set to deliver 40% oxygen. Within 30 minutes, the patient is much less agitated, and the respiratory rate is 10 breaths per minute and shallow. The patient seems sleepy and does not respond in an alert manner to verbal questions. Arterial blood gases are drawn with the following results:

What is the explanation for these blood gas results?

Discussion

Given this patient’s history, chronic hypoxemia probably increases peripheral chemoreceptor sensitivity enough (via mechanisms explained in this chapter) to have an effect on his normal ventilation. His initial PaO2 of 50 mm Hg is low enough to increase significantly peripheral chemoreceptor sensitivity to H+. It stands to reason that the relatively high fractional concentration of oxygen in inspired gas (FIO2) of 0.40 played a role in decreasing peripheral chemoreceptor sensitivity because the PaO2 increased to 95 mm Hg. Whatever the mechanism might be (whether it is removal of the hypoxic stimulus, worsening of the V˙/Q˙image ratio, or a combination of both), this patient hypoventilated in response to oxygen therapy as is shown by the increase in PaCO2 to 80 mm Hg. This acute increase in CO2 and the accompanying acidemia depress the central nervous system, causing lethargy, which can ultimately lead to a coma. Aside from the causative mechanism, the clinically important fact is that uncontrolled oxygen therapy can lead to hypoventilation and acute acidemia in patients who are chronically hypercapnic. For this reason, spontaneously breathing, hypoxemic, chronically hypercapnic patients with COPD who are experiencing exacerbations are generally given low concentrations of oxygen (24% to 28%). Devices that produce a fixed FIO2 regardless of the patient’s ventilatory pattern should be used. Initial oxygen therapy is monitored closely through arterial blood gases to detect acute CO2 retention and acidemia. Low levels of inspired oxygen often increase the arterial oxygen content quite effectively in these patients because their blood PO2 is on the steep part of the oxygen-hemoglobin equilibrium curve (see Chapter 8). In other words, small increases in PaO2 produce relatively large increases in oxygen content. However, concern about inducing hypoventilation, hypercapnia, and acidemia is never a justifiable reason for withholding oxygen from a patient with tissue hypoxia; tissue hypoxia has a far greater potential to be life threatening than hypercapnia and acidemia. The clinician must be prepared to mechanically ventilate these patients as necessary.

Cheyne-Stokes breathing, the respiratory rate and tidal volume gradually increase and then gradually decrease to complete apnea (absence of ventilation), which may last several seconds. The tidal volume and breathing frequency gradually increase again, repeating the cycle (Figure 11-11). This pattern occurs when cardiac output is low, as in congestive heart failure, which delays the blood transit time between the lungs and the brain.3 As shown in Figure 11-11, changes in respiratory center PCO2 lag behind changes in PaCO2. When increasing PaCO2 reaches the medullary neurons, ventilation is stimulated, decreasing the arterial blood PCO2. When this blood, now low in PaCO2, eventually reaches the medulla, it inhibits ventilation, but it is so slow to reach the medullary neurons that hyperventilation persists for an inappropriately long time. When the blood from the lung

CLINICAL FOCUS 11-5   Mechanical Hyperventilation of a Patient with Head Trauma

An automobile accident victim, previously healthy, sustained a closed head injury with accompanying high ICP. Mechanical ventilation in the intensive care unit is required. In ventilating this patient’s lungs, you can control the PaCO2. What is your goal in establishing an appropriate PaCO2?

Discussion

Clinical investigators showed more than 40 years ago that the volume of the swollen brain could be reduced by decreasing PaCO2. Since then, mechanical hyperventilation has been a cornerstone in managing elevated ICP associated with TBI.12 Hyperventilation decreases ICP by causing cerebral vasoconstriction, ultimately reducing cerebral blood volume. This subject is not without controversy; hyperventilation-induced cerebral vasoconstriction has the potential to reduce CBF to levels that cause cerebral hypoxia (ischemia). Over the last decade, this concern has dampened enthusiasm for hyperventilation in cases of TBI. Both the proponents and the opponents of hyperventilation recognize that TBI poses an ischemic threat to the brain; proponents believe that the reduction of CBF ultimately improves cerebral oxygenation by reducing the ICP, which helps sustain the cerebral perfusion pressure. Opponents point out that no other hypoxic organ in the body is treated by reducing its blood flow and oxygen supply. (Hyperventilation in this context is generally defined as a PaCO2 <35 mm Hg.12)

The debate centers around the question of whether a hyperventilation-induced decrease in CBF creates an additional hypoxic insult to the already ischemic brain and whether patients managed in this way have better clinical outcomes than patients in whom hyperventilation is not instituted. A comprehensive review of this subject published in 2005 concluded that no advantage in long-term clinical outcome could be shown in TBI, whether or not hyperventilation was used.12 The authors concluded that in TBI, hyperventilation therapy should be considered only for patients with high ICPs; no benefit can be expected if ICP is normal. They further concluded that hyperventilation is most appropriate the second or third day after injury because CBF is lowest in the first 24 hours after injury, and the risk of inducing ischemia through hyperventilation is greatest in this time frame. The authors advised against hyperventilating TBI patients to a PaCO2 less than 30 mm Hg because this increases the danger of cerebral ischemia. Finally, it is important to remember that hyperventilation is effective for only about 24 to 48 hours because compensatory renal elimination of bicarbonate restores the acid-base balance, negating the vasoconstrictive effect of hypocapnia.12 What is not controversial is that hypoventilation in patients with head trauma and increased ICPs is especially dangerous because hypercapnia dilates cerebral vessels and increases ICP further. Even opponents of hyperventilation generally maintain PaCO2 of patients with TBI in the low-normal range around 35 mm Hg.

finally reaches the medullary centers, its decreased PaCO2 greatly depresses ventilation to the point of apnea. PaCO2 then increases, but an increase in medullary center PCO2 is delayed because of the low blood flow rate. The brain eventually receives the high PaCO2 signal, and the cycle is repeated. Cheyne-Stokes breathing also may be caused by brain injuries in which the respiratory centers overrespond to changes in PCO2. In this situation, slight increases in PCO2 cause exaggerated increases in ventilation, and low PCO2 may completely turn off the medullary centers.3

Biot’s breathing is similar to Cheyne-Stokes breathing except tidal volumes have essentially the same depth. The mechanism for this pattern is unclear; it occurs in patients with lesions of the pons.13

Apneustic breathing (discussed previously) also indicates damage to the pons.13 Central reflex hyperpnea (formerly known as central neurogenic hyperventilation) is continuous deep breathing driven by abnormal neural stimuli. It is related to midbrain and upper pons damage that may occur with head trauma, severe brain hypoxia, or lack of blood flow to the brain.13 Conversely, in central reflex hypopnea (formerly known as central neurogenic hypoventilation), the respiratory centers do not respond appropriately to ventilatory stimuli such as CO2. Central reflex hypopnea is associated with head trauma, brain hypoxia, and narcotic suppression of the respiratory center.2

Carbon Dioxide and Cerebral Blood Flow

CO2 plays an important role in regulating cerebral blood flow (CBF). Its effect is mediated through the formation of hydrogen ions by CO2.12 Increased PCO2 dilates cerebral vessels, increasing CBF, whereas decreased PCO2 constricts cerebral vessels and reduces CBF. In patients with traumatic brain injury (TBI), the brain swells acutely; this increases the intracranial pressure (ICP) in the rigid skull to such high levels that blood supply to the brain might be cut off, causing cerebral hypoxia (ischemia)—increased ICP may exceed cerebral arterial pressure and stop blood flow. Normal ICP is less than 10 mm Hg; a pressure of 20 mm Hg places the brain at risk for ischemia and requires active treatment to reduce the ICP.12 The brain has a high oxygen requirement; it accounts for about 20% of the entire body’s resting oxygen consumption. To meet this oxygen demand, the body maintains a constant CBF of about 50 to 60 mL per 100 g of brain tissue per minute; CBF less than 18 mL/100 g/min is the threshold for cerebral ischemia.18 To sustain the CBF, cerebral perfusion pressure (CPP) of about 60 mm Hg must be maintained. CPP is the difference between mean arterial pressure and ICP; cerebral ischemia is likely to occur if CPP decreases to less than 55 mm Hg.12

Mechanical hyperventilation has been used for many years in TBI to reduce PaCO2 and reduce CBF and ICP. In patients with TBI, a cerebral blood volume reduction of only 0.5 to 0.7 mL decreases ICP by 1 mm Hg; on the other hand, for every 1-mm Hg acute reduction in PaCO2 (between 20 mm Hg and 60 mm Hg), there is a 3% reduction in CBF.12 Thus, although an acute reduction in PaCO2 reduces ICP, it also reduces CBF and potentially causes cerebral ischemia. In any event, hypoventilation in a patient with head trauma and a preexisting elevated ICP is especially dangerous because the resulting hypercapnia dilates cerebral vessels and elevates ICP even more.